In recent years, peptides have gained increasing relevance in regenerative medicine, precision medicine, and therapeutic strategies aimed at healthy longevity. Although historically their application was limited to specialized areas of biomedical research, they are now recognized as bioactive molecules with remarkable potential to modulate fundamental physiological processes, including tissue repair, the inflammatory response, cell regeneration, functional recovery, and the maintenance of biological homeostasis (Fosgerau & Hoffmann, 2015).
The scientific and clinical interest in peptides lies in their ability to act as highly specific molecular messengers. These molecules participate in complex cell signaling networks, interacting with specific receptors to trigger precise biological responses. Through this mechanism of action, peptides can influence key metabolic pathways and cellular processes related to cell proliferation, differentiation, migration, and survival.
In the context of regenerative medicine, peptides are frequently described as biological “master keys” due to their ability to activate endogenous repair and regeneration mechanisms. Rather than replacing physiological functions, these molecules act as regulatory signals that promote the activation of the body’s natural processes, helping to optimize cell communication and the adaptive response of tissues to damage or aging.
This ability to modulate specific biological functions with a high degree of selectivity has made peptides one of the areas of greatest interest within translational research, opening new perspectives for the development of therapeutic strategies aimed at improving tissue regeneration, functional recovery and the quality of life associated with healthy aging.
What are peptides?
Peptides are biomolecules composed of short chains of amino acids linked by peptide bonds. They are naturally produced in the body and participate in a wide variety of essential physiological processes, acting as signaling molecules capable of regulating communication between cells, tissues, and organs (Fosgerau & Hoffmann, 2015; Lau & Dunn, 2018).
From a biological perspective, peptides function as molecular messengers that interact with specific receptors to trigger intracellular signaling cascades. These pathways regulate fundamental processes such as gene expression, cell proliferation, differentiation, cell migration, energy metabolism, and cell survival mechanisms (Apostolopoulos et al., 2021; Otvos & Wade, 2014).
Numerous endogenous peptides actively participate in endocrine regulation, the immune response, modulation of inflammation, angiogenesis, wound healing, and tissue repair. Furthermore, they play a significant role in communication between stem cells, immune cells, and damaged tissues, contributing to the coordination of regeneration processes and the maintenance of tissue homeostasis (Lau & Dunn, 2018; Gagliardi et al., 2021).
La importancia de estas moléculas ha despertado un creciente interés en el campo de la medicina regenerativa debido a su capacidad para modular mecanismos biológicos específicos con un elevado grado de selectividad. A diferencia de muchas terapias convencionales, los péptidos pueden actuar sobre rutas de señalización concretas, favoreciendo respuestas fisiológicas controladas y minimizando efectos fuera del tejido diana (Fosgerau & Hoffmann, 2015).
Several studies have shown that aging is associated with alterations in cell communication networks, decreased tissue regenerative capacity, and changes in molecular signaling involved in repair processes. These observations have driven the development of therapeutic strategies based on bioactive peptides with the aim of optimizing tissue regeneration, modulating inflammation, and promoting healthy aging (López-Otín et al., 2023; Kennedy et al., 2014).
How do they act in cell regeneration?
Unlike many conventional therapeutic interventions that seek to replace altered physiological functions, bioactive peptides act primarily as modulators of cell signaling, promoting specific biological responses through the body’s natural mechanisms. Their main function is to interact with highly selective cell receptors, activating molecular cascades that regulate processes related to tissue repair, regeneration, and maintenance (Hamley, 2017; Fosgerau & Hoffmann, 2015).
Once bound to their receptors, peptides can trigger various intracellular signaling pathways involved in cell proliferation, migration of reparative cells, synthesis of structural proteins, angiogenesis, and modulation of the inflammatory response. These actions contribute to optimizing physiological recovery mechanisms in the face of injury, cellular stress, and degenerative processes associated with aging (Lau & Dunn, 2018; Apostolopoulos et al., 2021).
Depending on their biological characteristics and the receptors on which they act, certain peptides have demonstrated the ability to stimulate the synthesis of collagen and other components of the extracellular matrix, promote muscle regeneration, promote the formation of new blood vessels, modulate immune activity and reduce chronic low-grade inflammation, one of the main factors involved in tissue deterioration associated with aging (López-Otín et al., 2023; Kennedy et al., 2014).
Además, diversos estudios han demostrado que los péptidos pueden influir sobre procesos relacionados con la supervivencia celular, la protección frente al estrés oxidativo y la regulación de factores de crecimiento involucrados en la reparación tisular. Estas propiedades han convertido a los péptidos en una de las áreas de mayor interés dentro de la medicina regenerativa y la investigación en longevidad saludable (Otvos & Wade, 2014; Fosgerau & Hoffmann, 2015).
In simple terms, peptides function as highly specific biological instructions that allow cells to recognize when to activate repair, defense, or regeneration mechanisms. Rather than replacing biological functions, they facilitate more efficient cell communication, enabling the body to respond in a coordinated manner to tissue damage, inflammation, or accumulated cellular wear and tear.
Applications within regenerative medicine
Over the past decade, bioactive peptides have emerged as a tool of great interest in regenerative medicine due to their ability to modulate specific biological processes involved in tissue repair and maintenance. Their therapeutic potential has driven a growing number of investigations aimed at evaluating their role in functional recovery strategies, tissue regeneration, and healthy aging (Fosgerau & Hoffmann, 2015; Lau & Dunn, 2018).
At America Cell Bank, we maintain a constant commitment to scientific updates and rigorous evaluation of emerging technologies in regenerative medicine. Our approach is based on integrating current scientific evidence, quality standards, and expert medical oversight to provide reliable information on the advances that are transforming the future of advanced therapies.
Furthermore, there is a growing interest in the use of peptides as modulators of chronic low-grade inflammation, a biological phenomenon closely related to aging and multiple degenerative diseases. The ability of some peptides to influence immune activity and inflammatory processes has generated expectations regarding their potential application in strategies aimed at promoting healthy aging and preserving tissue function in the long term (Kennedy et al., 2014; López-Otín et al., 2023).
Other areas of research include its potential involvement in neuroprotective mechanisms, gastrointestinal repair, metabolic regulation, and protection against cellular stress. Although preclinical results and some initial clinical studies have shown promising findings, many of these applications remain under active investigation and require further evidence to fully establish their efficacy and safety in different clinical contexts (Otvos & Wade, 2014; Apostolopoulos et al., 2021).
Dentro de los enfoques contemporáneos de medicina regenerativa, los péptidos suelen integrarse en estrategias terapéuticas multimodales junto con terapias celulares, productos derivados de células madre, exosomas, factores de crecimiento y programas de optimización metabólica. Esta aproximación busca aprovechar la interacción entre diferentes mecanismos biológicos para favorecer procesos de reparación, recuperación funcional y mantenimiento de la homeostasis tisular (Gagliardi et al., 2021; Trounson & McDonald, 2015).
Differences between peptides, stem cells, and exosomes
Although peptides, stem cells, and exosomes are often grouped together within the field of regenerative medicine, each acts through different biological mechanisms and fulfills specific functions within the processes of tissue repair and maintenance.
Stem cells are cells with the capacity for self-renewal and differentiation that can contribute to tissue regeneration through direct and indirect mechanisms. In addition to their potential to generate different cell types, they exert important paracrine activity through the release of bioactive factors that modulate inflammation, promote tissue repair, and enhance cell communication (Caplan, 2017; Trounson & McDonald, 2015).
Por su parte, los exosomas son vesículas extracelulares de tamaño nanométrico liberadas por múltiples tipos celulares, incluidas las células madre. Estas estructuras contienen proteínas, lípidos, ARN mensajero, microARN y otras moléculas bioactivas capaces de transferir información biológica entre células. Gracias a esta función de comunicación intercelular, los exosomas participan en procesos relacionados con la regeneración tisular, la modulación inmunológica, la angiogénesis y la reparación de tejidos dañados (Rani et al., 2015; Kalluri & LeBleu, 2020).
Peptides, in contrast, are signaling molecules that act primarily by activating or modulating specific receptors and cellular pathways. Their function is to transmit precise biological instructions capable of triggering specific physiological responses, including processes associated with cell proliferation, the synthesis of structural proteins, inflammatory modulation, and tissue repair (Fosgerau & Hoffmann, 2015; Hamley, 2017).
From a biological perspective, these approaches should not necessarily be considered mutually exclusive. While stem cells contribute regenerative capacity and complex secretory activity, exosomes facilitate the transfer of molecular signals between cells, and peptides act as specific regulators of various signaling pathways. Due to these functional differences, numerous contemporary regenerative medicine strategies explore combining these tools to enhance complementary mechanisms of repair, functional recovery, and maintenance of tissue homeostasis (Galipeau & Sensébé, 2018; Gagliardi et al., 2021).
The integration of cell therapies, exosomes, bioactive peptides, and metabolic optimization strategies represents one of the fastest-growing areas within current translational research, aimed at developing increasingly precise interventions to promote regeneration and preserve tissue function throughout aging.
Safety, scientific evidence and future development
The field of therapeutic peptides has experienced significant growth over the past decades, driven by advances in molecular biology, protein engineering, and precision medicine. Currently, numerous peptides have been approved for specific clinical indications, while others continue to be evaluated in preclinical studies and clinical trials aimed at determining their efficacy, safety and pharmacological profile in different therapeutic areas (Fosgerau & Hoffmann, 2015; Lau & Dunn, 2018).
No obstante, es importante reconocer que el nivel de evidencia científica disponible varía considerablemente entre los diferentes péptidos y sus potenciales aplicaciones clínicas. Mientras algunas moléculas cuentan con respaldo derivado de estudios clínicos robustos y aprobación por agencias regulatorias internacionales, otras permanecen en etapas tempranas de investigación o disponen únicamente de evidencia preclínica limitada. Por esta razón, la evaluación crítica de la literatura científica y el cumplimiento de los marcos regulatorios vigentes constituyen elementos esenciales para su utilización responsable (Lee et al., 2019; Craik et al., 2021).
La calidad farmacéutica, la pureza molecular, la estabilidad del producto, los métodos de fabricación y la trazabilidad de los compuestos representan factores determinantes para garantizar la seguridad y reproducibilidad de cualquier intervención basada en péptidos. Asimismo, la supervisión por profesionales de la salud capacitados resulta fundamental para valorar indicaciones, contraindicaciones, posibles efectos adversos y expectativas terapéuticas realistas en cada paciente (Lau & Dunn, 2018; Fosgerau & Hoffmann, 2015).
The growing commercial interest in peptide-based therapies has highlighted the need to promote rigorous standards of quality, transparency, and scientific support. Various medical societies and regulatory bodies have emphasized the importance of differentiating between applications supported by solid clinical evidence and those that still require further validation through long-term, controlled studies (Lee et al., 2019).
Looking ahead, research is focused on developing increasingly specific, stable, and selective peptides capable of interacting with specific molecular targets involved in aging processes, tissue regeneration, chronic inflammation, and degenerative diseases. Integrating these molecules with emerging regenerative medicine tools, cell therapies, and personalized medicine strategies represents one of the most promising areas for developing innovative treatments aimed at improving biological function and quality of life for patients (Craik et al., 2021; López-Otín et al., 2023).
Peptides represent one of the areas of greatest interest within contemporary regenerative medicine due to their ability to specifically modulate cell signaling processes involved in tissue repair, the inflammatory response, and the maintenance of biological homeostasis. Their function as bioactive molecules capable of influencing fundamental physiological mechanisms has driven a growing number of investigations in fields related to regeneration, precision medicine, and healthy aging (Fosgerau & Hoffmann, 2015; Lau & Dunn, 2018).
Scientific advances in recent years have significantly expanded our understanding of how these molecules participate in cell communication and the regulation of multiple biological processes. Although numerous applications continue to be the subject of research and clinical validation, the available evidence suggests that peptides could play an increasingly important role in the development of innovative therapeutic strategies aimed at repairing and preserving tissue function (Craik et al., 2021; López-Otín et al., 2023).
El futuro de la medicina regenerativa probablemente estará marcado por enfoques integrados que combinen terapias celulares, exosomas, biomoléculas bioactivas y herramientas de medicina personalizada, con el objetivo de optimizar los mecanismos naturales de recuperación y adaptación del organismo. En este contexto, los péptidos continúan consolidándose como una plataforma terapéutica de gran interés científico y clínico.
At America Cell Bank, we maintain a constant commitment to scientific updates and rigorous evaluation of emerging technologies in regenerative medicine. Our approach is based on integrating current scientific evidence, quality standards, and expert medical oversight to provide reliable information on the advances that are transforming the future of advanced therapies.
References
- Apostolopoulos, V., Bojarska, J., Chai, T. T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Perera, C. O., Pickholz, M., Remko, M., Saviano, M., Skwarczynski, M., Toth, I., Uversky, V. N., & Aljabali, A. A. A. (2021). A global review on short peptides: Frontiers and perspectives. Molecules, 26(2), 430. https://doi.org/10.3390/molecules26020430
- Caplan, A. I. (2017). Mesenchymal stem cells: Time to change the name! Stem Cells Translational Medicine, 6(6), 1445–1451. https://doi.org/10.1002/sctm.17-0051
- Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013). The future of peptide-based drugs. Chemical Biology & Drug Design, 81(1), 136–147. https://doi.org/10.1111/cbdd.12055
- Fosgerau, K., & Hoffmann, T. (2015). Peptide therapeutics: Current status and future directions. Drug Discovery Today, 20(1), 122–128. https://doi.org/10.1016/j.drudis.2014.10.003
- Galipeau, J., & Sensébé, L. (2018). Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell, 22(6), 824–833. https://doi.org/10.1016/j.stem.2018.05.004
- Hamley, I. W. (2017). Small bioactive peptides for biomaterials design and therapeutics. Chemical Reviews, 117(24), 14015–14041. https://doi.org/10.1021/acs.chemrev.7b00522
- Kalluri, R., & LeBleu, V. S. (2020). The biology, function, and biomedical applications of exosomes. Science, 367(6478), eaau6977. https://doi.org/10.1126/science.aau6977
- Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., Rando, T. A., Richardson, A., Schadt, E. E., Wyss-Coray, T., & Sierra, F. (2014). Geroscience: Linking aging to chronic disease. Cell, 159(4), 709–713. https://doi.org/10.1016/j.cell.2014.10.039
- Lau, J. L., & Dunn, M. K. (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707. https://doi.org/10.1016/j.bmc.2017.06.052
- Lee, A. C. L., Harris, J. L., Khanna, K. K., & Hong, J. H. (2019). A comprehensive review on current advances in peptide drug development and design. International Journal of Molecular Sciences, 20(10), 2383. https://doi.org/10.3390/ijms20102383
- López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of aging: An expanding universe. Cell, 186(2), 243–278. https://doi.org/10.1016/j.cell.2022.11.001
- Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery, 20(4), 309–325. https://doi.org/10.1038/s41573-020-00135-8
- Otvos, L., Jr., & Wade, J. D. (2014). Current challenges in peptide-based drug discovery. Frontiers in Chemistry, 2, 62. https://doi.org/10.3389/fchem.2014.00062
- Rani, S., Ryan, A. E., Griffin, M. D., & Ritter, T. (2015). Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Molecular Therapy, 23(5), 812–823. https://doi.org/10.1038/mt.2015.44
- Trounson, A., & McDonald, C. (2015). Stem cell therapies in clinical trials: Progress and challenges. Cell Stem Cell, 17(1), 11–22. https://doi.org/10.1016/j.stem.2015.06.007
- Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: Current applications and future directions. Signal Transduction and Targeted Therapy, 7(1), 48. https://doi.org/10.1038/s41392-022-00904-4
